Select Language

Search

Insights

No match found

Services

No match found

Industries

No match found

People

No match found

Insights

No match found

Services

No match found

People

No match found

Industries

No match found

COVID-19: The Biden Presidency and What Lies Ahead

COVID-19 Insights January 26, 2021
COVID-19 Insights January 26, 2021
  •  Minute Read Clock/
  • ListenListen/ StopStop/
  • Text Bigger | Text Smaller Text

 

With Joe Biden sworn in as the 46th U.S. president, and on the day Canada marked the one-year anniversary of its first confirmed COVID-19 case, BMO hosted a live panel with internal and external experts to discuss the battle against the pandemic, from a health, markets and macroeconomic perspective, including where it will finally plateau. Moderated by Chief Investment Strategist Brian Belski, the call featured medical commentary from Dr. John Whyte, Chief Medical Officer, WebMD, and Dr. Howard Ovens, Emergency Physician and Chief Medical Strategy Officer of Sinai Health. BMO experts, Deputy Chief Economist Michael Gregory and Margaret Kerins, Head of FICC Macro Strategy, discussed the economic and fixed income and equity market outlooks for Canada and the United States.


Listen to full discussion.

TRANSCRIPT

BMO COVID-19 Insights podcast is live on all major channels including Apple, Google and Spotify.


Race to Vaccinate and the New Variants

While rates of infection, hospitalization and mortality due to COVID-19 have fallen in both countries, questions loom about new variants, whether they are potentially more deadly, and what impact they will have in the fight against the pandemic.

“And that's the reason why we really have to step up our vaccination plan,” Dr. Whyte said in opening the panel discussion. “We've had great development of vaccines, but where we've been lagging is the distribution.”

As of the end of January, some 420,000 people had died due to COVID-19 in the United States. The majority of those were in the last few months, although numbers continue to come down after the holiday surge.

According to official statistics, the U.S. saw some 25 million COVID-19 infections at the end of January, but Dr. Whyte said that figure doesn’t take into account all the people who contracted the virus and did not seek medical help. He said the real number could be as high as 70 million.

The United States needs to double its rate of vaccination, to about 2 million doses per day, if it is to stave off the pandemic and achieve herd immunity, with between 70-80 percent of the population, he said.

“So, we really need to develop a strategy to rev it up. We really need honestly to be getting at about 2 million a day, if we want to accomplish this by summer.”

“That's about 230 million people,” he said. “Right now, we only have vaccines that are two shots. So that's 460 million doses that we need to do here in the United States. So even if you think it's 75% of that population, we're still going to need about 345 million shots.”

Dr. Whyte pointed out that one of the first commitments President Biden made once he was sworn in was to vaccinate 100 million Americans in his first 100 days in office.1 They are indeed vaccinating a little over 1 million people a day; however, at that rate, he said, it could take a year to hit herd immunity.

1 On February 17, President Biden pledged to provide at least 600 million doses of COVID-19 vaccines by July 2021.

 

Pfizer, Moderna, Johnson & Johnson

Reaching more Americans faster may become more possible in coming months.

Pfizer and Moderna have announced that, combined, there will be 200 million additional doses by the end of March, and another 200 million at the end of June.

“I'm going to be honest, those are best case scenarios,” Dr. Whyte said. “As you know, there can always be issues in the supply chain.”

The other good news is that Johnson & Johnson will likely submit their request for emergency use authorization in February for a vaccine that will potentially require one dose instead of two. The company is working to produce 100 million doses that can be ready to be administered in coming months.

While herd immunity will eventually mean an end to the pandemic, Dr. Ovens cautioned that it will not help us out of the second wave that is currently in progress.

“With the exception of vaccinating our frail elderly in long term care, where this could be a big lifesaver, it is a bit of a distraction, because we can't vaccinate our way out of this second wave.”

It’s been proven internationally that strict lockdowns are the only way to curb the pandemic’s growth once there is widespread community transmission as we face now, Dr. Ovens continued, also echoing a building consensus among experts that both domestic and international travel need to be reduced.

Reasons for Optimism

At the same time, he listed numerous reasons for optimism.

There have been “really fantastic developments in testing, genomic sequencing, vaccination, therapeutics,” he said. “And I think the U.S. rejoining the World Health Organization, joining the COVAX group to try and support developing countries who need help getting their vaccinations – I think those are very important developments that are going to help us get all this back under control and help bring us out of this pandemic.”

THE ECONOMY – Winter Hump to Summer Jump

Even as Canada and the United States have begun to flatten the pandemic curve, increased restrictions and lockdowns in states and provinces have impacted the economic recovery curve, said BMO Deputy Chief Economist Michael Gregory, pointing at indicators like the latest job numbers for December in both countries.

“We were down 53,000 in household employment in Canada, payroll employment was down 140,000 in the U.S. in the month, and even retail sales in December in the U.S. were negative, suggesting that the real personal consumption expenditures figure for the month was also negative,” he said. “That'll be the second negative month in a row for real PCE.”

Gregory noted that uncertainty around continued government support programs in the U.S. may have weighed on consumer confidence.

He predicts, however, that the U.S. will still eke out slightly positive growth in the first quarter, 1% annualized, compared to an expected near-5% pace in the fourth quarter. In Canada, which had slightly more stringent restrictions and more onerous lockdowns, Gregory forecast a 3% annualized contraction in the first quarter, compared to a near-6% in the previous quarter.

He said, however, that restrictions and lockdowns will not have such a devastating impact as they did last spring, because businesses have become more accustomed to managing under COVID protocols.

Spring-Summer Rebound

Gregory said he was optimistic that this greater resilience, coupled with strong support for the manufacturing sector and a demand for goods, as well as a strong housing sector in both countries, will all help drive a rebound in the spring and summer months.

He pointed also to continued fiscal and monetary support in both countries to help people and businesses through the pandemic, including $70-to- $100 billion of spending yet to be determined that will be used to help stimulate the recovery phase in Canada as it comes out of the pandemic recession.

“We're looking for a pretty decent rebound through the spring and the summer months,” he said. “We're looking for healthy growth around 6.6% annualized on average in Q2 and Q3 for Canada, and 8% in the U.S.”2

Subject to change

Biden Bump

In the U.S., Gregory pointed to a proposed $1.9 trillion stimulus package to support the economy, noting, however, that there is some opposition from both sides of the political divide on the magnitude of the fiscal response.

“We are assuming, though, that we do get additional fiscal support,” he said, adding that for the time being, “We're penciling in something around half of what the initial proposal will be.”

Finally, Gregory noted a large jump in household saving on both sides of the border, equal to more than 6% of GDP, that will come to the fore in the shape of consumer spending as optimism builds about an end to the pandemic.

“That's a powerful backstop for the economy,” he said.

FICC – Reflation and the Financial Bubble Risk

Looking to fixed income, BMO Capital Markets Head of FICC Macro Strategy Margaret Kerins, said market pricing continues to oscillate with news around the fight against the pandemic, from infection rates to the speed of the vaccine rollout and expectations for stimulus.

She said there were three main themes dominating the fixed income markets, including: the reflation trade, financial market bubble risk and Fed messaging that front-end rates will be held at the zero bound for several years. She added that a slow-down in asset purchases will not occur in 2021.

“We did have a bear market run a few weeks ago and it's kind of consistent with, I think, the three main themes in the market currently,” she said, adding that the themes are very related. She said any undesired tightening of financial conditions due to the pricing of reflation, or the bursting of any asset price bubbles, would result in additional Fed accommodation.

10-Year Yields

Kerins noted that 10-year yields were pushed up to just over 118 bp a few weeks ago, in a massive 28-basis-point move, only to rally back down.

“We currently sit in the middle of the year-to-date range,” she said. “We think that the next move is likely to breach 1% on the downside, rather than move to 1.25%.”

Later in the year, she said the consensus trade is for a bear steepening in the market.

“We expect front-end yields to remain anchored by the Fed for the foreseeable future and we expect the Treasury yield curve to steepen. While the steepening trade is consensus at this time, we differ in that we think the move to higher long-end yields will be capped by the Fed and their desire to maintain extremely supportive financial conditions.”

Treasuries Must Clear

Kerins said one theme her team is thinking about at BMO is the amount of Treasury issuance relative to what the Fed has purchased during the pandemic period. BMO is forecasting for some $1.7 trillion in coupons to be to be issued into the market in 2021, including a base assumption of half the $1.9 trillion stimulus package being approved and some $960 billion the Fed is already expected to purchase.

When stimulus was injected at the start of the pandemic, Kerins said, it had a secondary effect of pushing investors out of the risk curve into corporate debt and equities.

“And so, one of the things that we're looking at, one of the themes that we're looking at this year, is the evolution of Treasury supply and demand in the marketplace,” she said. “Because Treasury supply has to clear the market, people will buy it, and it really becomes a matter of, how do they make room for the supply? Do they sell some of those risk assets that they have purchased in 2020?”

THE MARKETS – Best Assets in the World

BMO Capital Markets Chief Investment Strategist Brian Belski said 2021 will mark a year when stimulus drives unprecedented earnings growth in Canada and the United States, but cautioned against premature optimism for a return to normal.

“We think the effect on the stock market is all about the U.S. and Canada having the best equity assets in the world, period,” Belski said. “That's what the stimulus is purchasing. That's why people are investing in North America.”

“We do believe that the themes for 2021 are going to be about unprecedented earnings growth, especially in the second half,” he added, again crediting government stimulus.

He advised investors not to count on a “return to normal” trade for 2021, saying that might be premature.

Bull Roars On

Belski said the 10-year bull market will continue for another decade, despite the pandemic, but said the next 10 years will be very different, and would reward more fundamental investing and more bottom-up stock picking.

He said that Canada continues to present a value proposition with respect to the U.S., and forecast that the TSX will close the year at 19,500, and $1,100 of earnings.

“We continue to favor sectors like financials, materials and consumer discretionary, industrials in Canada,” he said.

In the United States, Belski has a year-end target for the S&P 500 of 4,200. He said his favorite sectors heading into the 2021 continue to be financials, consumer discretionary and industrials.

“We think those are areas that the majority of our institutional clients around the world are massively underweight, especially the financial side of things,” he said. “You know, we're good at a couple things in the United States and Canada, and one of them is spending money ... and we still think that the Amazons, the Lulus and the lifestyle stocks are going to continue to be quite strong.

Read more
Brian Belski Chief Investment Strategist
Michael Gregory, CFA Deputy Chief Economist and Managing Director

PART 1

North American Investment Strategy: 2021 Market Outlook

Brian Belski February 04, 2021

  While 2020 has been a challenging year, it’s also highlighted our resilience and determination. Those qualities were evident in the U…


PART 3

NextGen Treasury: Your Digital Roadmap

Marc-Andre Bergeron February 09, 2021

  Digitizing payments has become more important than ever as organizations look to increase working capital, create efficiencies, potentially…


PART 4

Deep Dive into Debt - How Retail Borrowed to Health through COVID

Simeon Siegel, CFA April 06, 2021

  More retailers are borrowing under COVID than during the Global Financial Crisis Retailers have borrowed multiples higher tha…


PART 5

The ‘E’, ‘S’ and ‘G’ in Mining

Magali Gable April 21, 2021

  At our 30th Annual Global Metals & Mining Conference this year, producer after producer engaged on the subject of sustainable mining in…


PART 6

The Changing Landscape of U.S. Trading

None May 21, 2021

  Changes to rule 606(b), the transparency and the NMS market data rule will increase data transparency and level the playing field for…


PART 7

COVID-19: Biden's First 100 Days: Tracking the Road to Recovery

Dan Barclay June 14, 2021

  With President Joe Biden cresting the first 100 days of his administration, experts are forecasting a strong economic rebound in the United…


PART 8

IN Tune: Food and Ag Takeaways From the Farm to Market Conference

Joel Jackson, P.Eng., CFA, Kelly Bania July 02, 2021

  IN Tune is a podcast featuring Equity Research analysts from BMO Capital Markets. Our episodes explore key emerging themes, trend…


PART 9

Extraordinary New Drivers Mean U.S. M&A has Room to Run

Lyle Wilpon July 26, 2021

That we’re living through one of the most robust M&A markets in living memory will not come as news to anyone. That markets are firing on…


PART 10

Accelerating the Road to Recovery

Dan Barclay August 16, 2021

  What kind of headwinds can we expect and what are the risks? Will inflation woes drive a change in monetary policy? BMO Capital Markets…


PART 11

The Delta Surge and Impacts on a Reopening

Brian Belski October 27, 2021

  On September 28, BMO hosted a panel to provide an update on the current state of the pandemic and an outlook on what it means for the marke…


PART 12

The Best of Both Worlds: The Future of Work in Capital Markets

Dan Barclay, Aine O’Flynn October 07, 2021

  It’s not that long ago that the physical pitch book was entrenched in deal-making lore, for decades thumped down on boardroom tables …




You might also be interested in